Opinion

Video

Diagnostic Tests for Kidney Cancer

Urologists provide an overview of diagnostic tests for patients with kidney cancer, highlighting lab tests, imaging, and considerations for biopsy.

Current Time 0:00
Duration 2:34
Loaded: 6.39%
Stream Type LIVE
Remaining Time 2:34
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected
    • en (Main), selected
    Related Videos
    Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
    Strategies to bridge gender disparities in AAS and citations in the oncology literature
    Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC
    Jad Chahoud, MD, on first-line zanzalintinib plus nivolumab for advanced ccRCC
    Reflecting on NMIBC Progress: Highlights From AUA 2025 and What’s Ahead
    Reflecting on NMIBC Progress: Highlights From AUA 2025 and What’s Ahead
    Navigating Access Barriers: Resources to Support New Treatment Access
    Navigating Access Barriers: Resources to Support New Treatment Access
    Overcoming Challenges in Accessing New Therapies for NMIBC
    Overcoming Challenges in Accessing New Therapies for NMIBC
    1 expert in this video
    Selecting Between Receptor Pathway Inhibitors for mHSPC
    1 expert in this video
    The Use of Ultra-Low PSA in Specific Patient Profiles
    2 experts are featured in this series.
    The MOA of TLX250
    1 expert is featured in this series.
    The importance of studying efficacy and safety of treatment in Black patients with mHSPC
    2 experts are featured in this series.
    The ZIRCON Trial
    Related Content
    3d rendered medically accurate illustration of kidney cancer | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
    June 6th 2025

    Pivotal trial of histotripsy system for kidney tumors reaches enrollment goal

    Hannah Clarke
    Data from the #HOPE4KIDNEY trial is intended to support submission for regulatory clearance of the Edison Histotripsy System.
    Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
    June 2nd 2025

    Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP

    Amy M. Pearlman, MD
    Jad Chahoud, MD, MPH
    June 5th 2025

    Zanzalintinib plus nivolumab shows safety, efficacy for stage 4 RCC

    Benjamin P. Saylor
    ORR in the zanzalintinib plus nivolumab arm was 63% (95% CI: 46-77) vs 40% (95% CI: 25-57) in the zanzalintinib plus nivolumab/relatlimab arm.
    Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
    May 17th 2025

    Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

    Amy M. Pearlman, MD Alex Tatem, MD
    Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
    Medically accurate illustration of kidney cancer | Image Credit: © Crystal light - stock.adobe.com
    June 1st 2025

    Adjuvant pembrolizumab continues to show DFS, OS benefits for ccRCC at 5-year assessment

    Silas Inman
    "These long-term results continue to support [pembrolizumab's] use as a standard of care for patients at increased risk of recurrence," says Naomi B. Haas, MD.
    Subcutaneous nivolumab approved in EU, Canada for solid tumors
    May 28th 2025

    Subcutaneous nivolumab approved in EU, Canada for solid tumors

    Hannah Clarke
    The approvals are supported by findings from the phase 3 CheckMate-67T trial.
    © 2025 MJH Life Sciences

    All rights reserved.